Knockdown or inhibition of aldo-keto reductase 1B10 inhibits pancreatic carcinoma growth via modulating Kras-E-cadherin pathway
about
Structural Determinants of the Selectivity of 3-Benzyluracil-1-acetic Acids toward Human Enzymes Aldose Reductase and AKR1B10Aldo-Keto Reductase Family 1 Member B10 Inhibitors: Potential Drugs for Cancer Treatment.Novel chemical scaffolds of the tumor marker AKR1B10 inhibitors discovered by 3D QSAR pharmacophore modeling.TGFβ-induced switch from adipogenic to osteogenic differentiation of human mesenchymal stem cells: identification of drug targets for prevention of fat cell differentiation.Prognostic significance of AKR1B10 gene expression in hepatocellular carcinoma and surrounding non-tumorous liver tissue.High expression of AKR1B10 predicts low risk of early tumor recurrence in patients with hepatitis B virus-related hepatocellular carcinoma.Gedunin inhibits pancreatic cancer by altering sonic hedgehog signaling pathway.Inhibition of mutant KrasG12D-initiated murine pancreatic carcinoma growth by a dual c-Raf and soluble epoxide hydrolase inhibitor t-CUPM.Expression of AKR1B10 as an independent marker for poor prognosis in human oral squamous cell carcinoma.The hop-derived compounds xanthohumol, isoxanthohumol and 8-prenylnaringenin are tight-binding inhibitors of human aldo-keto reductases 1B1 and 1B10.Potential of AKR1B10 as a Biomarker and Therapeutic Target in Type 2 Leprosy Reaction
P2860
Q27702584-C6AF0A1B-7749-40EA-BA72-FEEC13379554Q33600379-92163BDD-0D99-4E97-97F8-DEA4AD33E612Q35655693-8D621B9B-3430-40B4-9E9D-3B02FC8D0E58Q37209580-A2470943-3DE2-43FB-8638-91299CA6B1A0Q37582227-56EC21FB-15D6-48D0-82BC-DA001A9257B4Q37633872-92D6F50B-8C1E-483D-A122-60176521DAA8Q37706853-1CD43D0A-DC0E-41BA-B091-15643E82BD21Q38810588-D4C289C4-830E-4CFA-8FFD-9FD2CCA7AE34Q48116483-C815593C-9D9B-4D73-B04E-F0BE19792863Q52658650-34F9E366-57DC-4493-8BAF-C54C2A56F077Q57492406-E6A1EAD0-25E4-4662-98F5-5E268CC6C058
P2860
Knockdown or inhibition of aldo-keto reductase 1B10 inhibits pancreatic carcinoma growth via modulating Kras-E-cadherin pathway
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Knockdown or inhibition of ald ...... lating Kras-E-cadherin pathway
@en
type
label
Knockdown or inhibition of ald ...... lating Kras-E-cadherin pathway
@en
prefLabel
Knockdown or inhibition of ald ...... lating Kras-E-cadherin pathway
@en
P2093
P2860
P1433
P1476
Knockdown or inhibition of ald ...... lating Kras-E-cadherin pathway
@en
P2093
Guang-Yu Yang
Wanying Zhang
P2860
P304
P356
10.1016/J.CANLET.2014.09.031
P407
P577
2014-10-07T00:00:00Z